Pulse Biosciences initiated at Buy; Freedom Capital Markets sets $73 target
Freedom Capital Markets initiated Pulse Biosciences at Buy and announced a $73.00/share price target, according to Benzinga ratings actions. (TradingView News)
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.